Sex differences in plasma cocaine levels and subjective effects after acute cocaine administration in human volunteers SE Lukas, M Sholar, LH Lundahl, X Lamas, E Kouri, JD Wines, L Kragie, ... Psychopharmacology 125 (4), 346-354, 1996 | 292 | 1996 |
Oral administration of glucagon-like peptide 1 or peptide YY 3-36 affects food intake in healthy male subjects RE Steinert, B Poller, MC Castelli, J Drewe, C Beglinger The American journal of clinical nutrition 92 (4), 810-817, 2010 | 106 | 2010 |
Oral administration of glucagon-like peptide 1 or peptide YY 3-36 affects food intake in healthy male subjects RE Steinert, B Poller, MC Castelli, J Drewe, C Beglinger The American journal of clinical nutrition 92 (4), 810-817, 2010 | 106 | 2010 |
Orally administered glucagon‐like peptide‐1 affects glucose homeostasis following an oral glucose tolerance test in healthy male subjects RE Steinert, B Poller, MC Castelli, K Friedman, AR Huber, J Drewe, ... Clinical Pharmacology & Therapeutics 86 (6), 644-650, 2009 | 69 | 2009 |
Assessing pregnancy risks of azole antifungals using a high throughput aromatase inhibition assay L Kragie, SD Turner, CJ Patten, CL Crespi, DM Stresser Endocrine research 28 (3), 129-140, 2002 | 52 | 2002 |
Aromatase in primate pregnancy: a review L Kragie Endocrine research 28 (3), 121-128, 2002 | 49 | 2002 |
Membrane iodothyronine transporters part I: review of physiology L Kragie Endocrine Research 20 (4), 319-341, 1994 | 47 | 1994 |
Benzodiazepines inhibit temperature-dependent L-[125I] triiodothyronine accumulation into human liver, human neuroblast, and rat pituitary cell lines. L Kragie, D Doyle Endocrinology 130 (3), 1211-1216, 1992 | 35 | 1992 |
Stoichiometry and apparent dissociation constant of the calcium-arsenazo III reaction under physiological conditions Z Ahmed, L Kragie, JA Connor Biophysical journal 32 (3), 907-920, 1980 | 35 | 1980 |
Composition and method of alleviating adverse side effects and/or enhancing efficacy of agents that inhibit aromatase L Kragie US Patent App. 10/474,838, 2004 | 34 | 2004 |
Membrane iodothyronine transporters part II: review of protein biochemistry L Kragie Endocrine research 22 (2), 95-119, 1996 | 23 | 1996 |
Neuropsychiatric implications of thyroid hormone and benzodiazepine interactions L Kragie Endocrine research 19 (1), 1-32, 1993 | 15 | 1993 |
Computer-assisted molecular modeling of benzodiazepine and thyromimetic inhibitors of the HepG2 iodothyronine membrane transporter. L Kragie, ML Forrester, V Cody, M McCourt Molecular Endocrinology 8 (3), 382-391, 1994 | 13 | 1994 |
Altered peripheral benzodiazepine receptor binding in cardiac and liver tissues from thyroidectomized rats L Kragie, R Smiehorowski Life sciences 55 (24), 1911-1918, 1994 | 13 | 1994 |
Rat cardiac calcium channels and their relationships with β-adrenergic and muscarinic receptors in hypothyroidism L Kragie, YW Kwon, R Smiehorowski Endocrine research 19 (1), 57-71, 1993 | 11 | 1993 |
Measures of skeletal muscle calcium channels and acetylcholine receptors in thyroidectomized rats L Kragie, R Smiehorowski Endocrine research 19 (2-3), 207-219, 1993 | 10 | 1993 |
Method of treating vitamin B12 deficiency C Castelli, L Kragie US Patent 8,557,792, 2013 | 9 | 2013 |
Theophylline—an alternative therapy for bradyarrhythmia in the elderly L Kragie, B Sekovski Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 12 (4 …, 1992 | 9 | 1992 |
Method of treating vitamin B12 deficiency C Castelli, L Kragie US Patent 8,022,048, 2011 | 5 | 2011 |
Acetylcholinesterase activity in fast-twitch skeletal muscle from thyroidectomized rats L Kragie, ME Stock Endocrine research 20 (1), 47-57, 1994 | 5 | 1994 |